View in EDS

Favorable outcomes with fludarabine, melphalan, and total-body irradiation 8-12Gy as an intensified conditioning regimen for adult allogeneic HCT.

Saved in:
Bibliographic Details
Title: Favorable outcomes with fludarabine, melphalan, and total-body irradiation 8-12Gy as an intensified conditioning regimen for adult allogeneic HCT.
Authors: Kubo T; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: suzukure.joker@gmail.com., Yamamoto H; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: hhhisashi@toranomon.gr.jp., Watanabe O; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: oty.noisynose@icloud.com., Taya Y; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: y.tayataya@gmail.com., Nishida A; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: a-nishida@ymail.ne.jp., Takagi S; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: shinsukewwwtakagi@icloud.com., Yamaguchi K; Department of Hematology, Toranomon Hospital Kajigaya, 1-3-1 Kajigaya, Takatsu-ku, Kawasaki, Kanagawa 213-8587, Japan. Electronic address: kyo.ymg@gmail.com., Kageyama K; Department of Hematology, Toranomon Hospital Kajigaya, 1-3-1 Kajigaya, Takatsu-ku, Kawasaki, Kanagawa 213-8587, Japan. Electronic address: koseikageyama@yahoo.co.j., Kaji D; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: kazykazy613@yahoo.co.jp., Ishiwata K; Department of Hematology, Toranomon Hospital Kajigaya, 1-3-1 Kajigaya, Takatsu-ku, Kawasaki, Kanagawa 213-8587, Japan. Electronic address: kazboo1979@gmail.com., Asano-Mori Y; Department of Transfusion Medicine, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ward, Tokyo 105-8470, Japan. Electronic address: yuki-am@toranomon.gr.jp., Yamamoto G; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: gyamamot-tky@umin.ac.jp., Wake A; Department of Hematology, Toranomon Hospital Kajigaya, 1-3-1 Kajigaya, Takatsu-ku, Kawasaki, Kanagawa 213-8587, Japan. Electronic address: wake@orange.ocn.ne.jp., Taniguchi S; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: taniguchi-s@hamanomachi.jp., Uchida N; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: nuchida@toranomon.gr.jp.
Source: Leukemia research [Leuk Res] 2026 Mar; Vol. 162, pp. 108183. Date of Electronic Publication: 2026 Feb 04.
Publication Type: Journal Article
Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41650718
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Favorable outcomes with fludarabine, melphalan, and total-body irradiation 8-12Gy as an intensified conditioning regimen for adult allogeneic HCT.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kubo+T%22">Kubo T</searchLink>; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: suzukure.joker@gmail.com.<br /><searchLink fieldCode="AU" term="%22Yamamoto+H%22">Yamamoto H</searchLink>; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: hhhisashi@toranomon.gr.jp.<br /><searchLink fieldCode="AU" term="%22Watanabe+O%22">Watanabe O</searchLink>; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: oty.noisynose@icloud.com.<br /><searchLink fieldCode="AU" term="%22Taya+Y%22">Taya Y</searchLink>; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: y.tayataya@gmail.com.<br /><searchLink fieldCode="AU" term="%22Nishida+A%22">Nishida A</searchLink>; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: a-nishida@ymail.ne.jp.<br /><searchLink fieldCode="AU" term="%22Takagi+S%22">Takagi S</searchLink>; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: shinsukewwwtakagi@icloud.com.<br /><searchLink fieldCode="AU" term="%22Yamaguchi+K%22">Yamaguchi K</searchLink>; Department of Hematology, Toranomon Hospital Kajigaya, 1-3-1 Kajigaya, Takatsu-ku, Kawasaki, Kanagawa 213-8587, Japan. Electronic address: kyo.ymg@gmail.com.<br /><searchLink fieldCode="AU" term="%22Kageyama+K%22">Kageyama K</searchLink>; Department of Hematology, Toranomon Hospital Kajigaya, 1-3-1 Kajigaya, Takatsu-ku, Kawasaki, Kanagawa 213-8587, Japan. Electronic address: koseikageyama@yahoo.co.j.<br /><searchLink fieldCode="AU" term="%22Kaji+D%22">Kaji D</searchLink>; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: kazykazy613@yahoo.co.jp.<br /><searchLink fieldCode="AU" term="%22Ishiwata+K%22">Ishiwata K</searchLink>; Department of Hematology, Toranomon Hospital Kajigaya, 1-3-1 Kajigaya, Takatsu-ku, Kawasaki, Kanagawa 213-8587, Japan. Electronic address: kazboo1979@gmail.com.<br /><searchLink fieldCode="AU" term="%22Asano-Mori+Y%22">Asano-Mori Y</searchLink>; Department of Transfusion Medicine, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ward, Tokyo 105-8470, Japan. Electronic address: yuki-am@toranomon.gr.jp.<br /><searchLink fieldCode="AU" term="%22Yamamoto+G%22">Yamamoto G</searchLink>; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: gyamamot-tky@umin.ac.jp.<br /><searchLink fieldCode="AU" term="%22Wake+A%22">Wake A</searchLink>; Department of Hematology, Toranomon Hospital Kajigaya, 1-3-1 Kajigaya, Takatsu-ku, Kawasaki, Kanagawa 213-8587, Japan. Electronic address: wake@orange.ocn.ne.jp.<br /><searchLink fieldCode="AU" term="%22Taniguchi+S%22">Taniguchi S</searchLink>; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: taniguchi-s@hamanomachi.jp.<br /><searchLink fieldCode="AU" term="%22Uchida+N%22">Uchida N</searchLink>; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Electronic address: nuchida@toranomon.gr.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227706787%22">Leukemia research</searchLink> [Leuk Res] 2026 Mar; Vol. 162, pp. 108183. <i>Date of Electronic Publication: </i>2026 Feb 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pergamon+Press%22">Pergamon Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7706787 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-5835 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201452126%22">01452126 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41650718
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.leukres.2026.108183
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 108183
    Titles:
      – TitleFull: Favorable outcomes with fludarabine, melphalan, and total-body irradiation 8-12Gy as an intensified conditioning regimen for adult allogeneic HCT.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kubo T
      – PersonEntity:
          Name:
            NameFull: Yamamoto H
      – PersonEntity:
          Name:
            NameFull: Watanabe O
      – PersonEntity:
          Name:
            NameFull: Taya Y
      – PersonEntity:
          Name:
            NameFull: Nishida A
      – PersonEntity:
          Name:
            NameFull: Takagi S
      – PersonEntity:
          Name:
            NameFull: Yamaguchi K
      – PersonEntity:
          Name:
            NameFull: Kageyama K
      – PersonEntity:
          Name:
            NameFull: Kaji D
      – PersonEntity:
          Name:
            NameFull: Ishiwata K
      – PersonEntity:
          Name:
            NameFull: Asano-Mori Y
      – PersonEntity:
          Name:
            NameFull: Yamamoto G
      – PersonEntity:
          Name:
            NameFull: Wake A
      – PersonEntity:
          Name:
            NameFull: Taniguchi S
      – PersonEntity:
          Name:
            NameFull: Uchida N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-5835
          Numbering:
            – Type: volume
              Value: 162
          Titles:
            – TitleFull: Leukemia research
              Type: main
ResultId 1